PMCC Staff Publications

pmcc logo sml



Here are the staff publications for July 2018.

Compiled by the Health Sciences Library (RMH, RWH, PMCC and Victorian Mental Health) 6th August 2018.


1. Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar R, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, Investigators K, Bolla MK, Wang Q, Jones ME, Schoemaker MJ, Keeman R, Easton DF, Swerdlow AJ, Sherman ME, Schmidt MK, Pharoah PD, Garcia-Closas M. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. International Journal of Cancer 2018;143:746-57.

2. Achen MG, Stacker SA. Exit Stage Left: A Tumor Cell's Journey from Lymph Node to Beyond. Trends in Cancer 2018;4:519-22.

3. Ager B, Jansen J, Porter D, Phillips KA, Glassey R, Butow P. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy. Breast 2018;40:156-64.

4. Ager BJ, Gallardo-Rincon D, de Leon DC, Chavez-Blanco A, Chuang L, Duenas-Gonzalez A, Gomez-Garcia E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Perez-Plasencia C, Plante M, Poveda A, Gaffney DK. Advancing clinical research globally: Cervical cancer research network from Mexico. Gynecologic Oncology Reports 2018;25:90-3.

5. Chen A, Sceneay J, Godde N, Kinwel T, Ham S, Thompson EW, Humbert PO, Moller A. Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene 2018;37:4214-25.

6. Collins A, Sundararajan V, Burchell J, Millar J, McLachlan SA, Krishnasamy M, Le BH, Mileshkin L, Hudson P, Philip J. Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer. Journal of Pain and Symptom Management 2018;56:185-94.

7. Daniel PM, Filiz G, Tymms MJ, Ramsay RG, Kaye AH, Stylli SS, Mantamadiotis T. Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures. Experimental and Molecular Pathology 2018;105:23-31.

8. Devlin JR, Verschuren EW. More than a Tumor Suppressor: E-Cadherin Loss Drives Lung Cancer Metastasis. American Journal of Respiratory Cell and Molecular Biology 2018;59:141-2.

9. Dingle AM, Yap KK, Gerrand YW, Taylor CJ, Keramidaris E, Lokmic Z, Kong AM, Peters HL, Morrison WA, Mitchell GM. Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering. Angiogenesis 2018;21:581-97.

10. Fortuno C, James PA, Young EL, Feng B, Olivier M, Pesaran T, Tavtigian SV, Spurdle AB. Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants. Human Mutation 2018;39:1061-9.

11. Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Lang I, Gomez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE, Jr., Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England Journal of Medicine 2018;379:122-37.

12. Glassey R, O'Connor M, Ives A, Saunders C, kConFab I, O'Sullivan S, Hardcastle SJ. Patients' perspectives and experiences concerning barriers to accessing information about bilateral prophylactic mastectomy. Breast 2018;40:116-22.

13. Halse H, Colebatch AJ, Petrone P, Henderson MA, Mills JK, Snow H, Westwood JA, Sandhu S, Raleigh JM, Behren A, Cebon J, Darcy PK, Kershaw MH, McArthur GA, Gyorki DE, Neeson PJ. Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma. Scientific Reports 2018;8:11158.

14. Hanson ED, Sakkal S, Evans WS, Violet JA, Battaglini CL, McConell GK, Hayes A. Altered stress hormone response following acute exercise during prostate cancer treatment. Scandinavian Journal of Medicine and Science in Sports 2018;28:1925-33.

15. Hirshoren N, Ruskin O, McDowell LJ, Magarey M, Kleid S, Dixon BJ. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival. Otolaryngology--Head and Neck Surgery 2018;159:293-9.

16. Hofman MS, Iravani A, Nzenza T, Murphy DG. Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging. Urologic Clinics of North America 2018;45:503-24.

17. Keam SP, Gulati T, Gamell C, Caramia F, Arnau GM, Huang C, Schittenhelm RB, Kleifeld O, Neeson PJ, Williams SG, Haupt Y. Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue. Radiation and Environmental Biophysics 2018;57:241-9.

18. Kim SH, Redvers RP, Chi LH, Ling X, Lucke AJ, Reid RC, Fairlie DP, Martin A, Anderson RL, Denoyer D, Pouliot N. Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis. Disease Models & Mechanisms 2018;11.

19. Lawrentschuk N. Editorial Comment. Journal of Urology 2018;200:308.

20. Lawrentschuk N. Editorial Comment. Journal of Urology 2018;200:359.

21. Li MH, Bolshinsky V, Ismail H, Ho KM, Heriot A, Riedel B. Comparison of Duke Activity Status Index with cardiopulmonary exercise testing in cancer patients. Journal of Anesthesia 2018;32:576-84.

22. Lindemann K, Gao B, Mapagu C, Fereday S, Emmanuel C, Alsop K, Traficante N, Harnett PR, Bowtell DDL, deFazio A. Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance. Gynecologic Oncology 2018;150:239-46.

23. Matthews KL, Baird M, Duchesne G. Using Online Meeting Software to Facilitate Geographically Dispersed Focus Groups for Health Workforce Research. Qualitative Health Research 2018;28:1621-8.

24. Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani NI, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine 2018;379:341-51.

25. Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Peach H, Oudit D, Geh J, Dziewulski P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Annals of Surgical Oncology 2018;25:2541-9.

26. Pleines I, Lebois M, Gangatirkar P, Au AE, Lane RM, Henley KJ, Kauppi M, Corbin J, Cannon P, Bernardini J, Alwis I, Jarman KE, Ellis S, Metcalf D, Jackson SP, Schoenwaelder SM, Kile BT, Josefsson EC. Intrinsic apoptosis circumvents the functional decline of circulating platelets but does not cause the storage lesion. Blood 2018;132:197-209.

27. Risbridger GP, Toivanen R, Taylor RA. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models. Cold Spring Harbor Perspectives in Medicine 2018;8.

28. Sakthianandeswaren A, Parsons MJ, Mouradov D, MacKinnon RN, Catimel B, Liu S, Palmieri M, Love C, Jorissen RN, Li S, Whitehead L, Putoczki TL, Preaudet A, Tsui C, Nowell CJ, Ward RL, Hawkins NJ, Desai J, Gibbs P, Ernst M, Street I, Buchert M, Sieber OM. MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors. Cancer Discovery 2018;8:988-1005.

29. Slaney CY, Wang P, Darcy PK, Kershaw MH. CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment. Cancer Discovery 2018;8:924-34.

30. Solomon BJ, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Tang Y, Wilner KD, Blackhall F, Mok TS. Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer. Journal of Clinical Oncology 2018;36:2251-8.

31. Wagle MV, Marchingo JM, Howitt J, Tan SS, Goodnow CC, Parish IA. The Ubiquitin Ligase Adaptor NDFIP1 Selectively Enforces a CD8(+) T Cell Tolerance Checkpoint to High-Dose Antigen. Cell Reports 2018;24:577-84.

32. Wolf J, Connell TG, Allison KJ, Tang L, Richardson J, Branum K, Borello E, Rubnitz JE, Gaur AH, Hakim H, Su Y, Federico SM, Mechinaud F, Hayden RT, Monagle P, Worth LJ, Curtis N, Flynn PM. Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial. Lancet Infectious Diseases 2018;18:854-63.